Estrogen and Progesterone Receptor Status as Prognostic Indicators in Patients with Optimally Cytoreduced Stage IIIc Serous Cystadenocarcinoma of the Ovary

Author： Geisler J.P.   Wiemann M.C.   Miller G.A.   Geisler H.E.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.60, Iss.3, 1996-03, pp. : 424-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian Serous Papillary Cystadenocarcinoma Stage IIIC in a 19-Year-Old

By Laframboise S.   Dubuc-Lissoir J.  

Gynecologic Oncology, Vol. 64, Iss. 2, 1997-02 ,pp. : 279-281

Elsevier

Access to resources Recommend Favorite

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

By Tsutsui S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 1, 2002-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor

By              

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3286-3292

Spandidos Publications

Access to resources Recommend Favorite

Impact of metastatic estrogen receptor and progesterone receptor status on survival

By Lower Elyse  

Breast Cancer Research and Treatment, Vol. 90, Iss. 1, 2005-03 ,pp. : 65-70

Springer Publishing Company

Access to resources Recommend Favorite

miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status

By            

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1027-1032

Spandidos Publications

Access to resources Recommend Favorite